DRUG · Mapped RxNorm record
Atorvastatin
Normalized identity: atorvastatinView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Statin TReatment for COVID-19 to Optimise NeuroloGical recovERy
NCT04904536
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
OTHER · Unmapped registry intervention
Standard Care
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedStatin TReatment for COVID-19 to Optimise NeuroloGical recovERy
Design: INTERVENTIONAL · Status: ACTIVE NOT RECRUITING · Phase: PHASE3
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Neurocognitive Impairment, Mildunresolved
Interventions
AtorvastatinDRUG · verified · RxNorm: atorvastatin
Standard CareOTHER
Sponsors & collaborators
The George Institutelead sponsor
University of Sydneycollaborator
Monash Universitycollaborator
The Alfredcollaborator
Universidad del Desarrollocollaborator
Chinese University of Hong Kongcollaborator
Clinica Alemana de Santiagocollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04904536 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.